Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site's displayed revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedAn NIH banner announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” across NIH content, with updates and FAQs available.SummaryDifference0.5%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer revision marker updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedThe History page now displays a new revision label, v3.7.0, replacing the previous v3.6.6. This indicates a platform update that changes the page's versioning and presentation without altering study data.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision label was added (v3.6.6) replacing the previous v3.6.5 in the page's history. This reflects a backend update to the record history interface rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.